Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto -2021/22 parent results

May 12 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            101.21          101.01                                
                                 (-5.1 pct)                              
  Operating         16.72           13.02                                
                                 (-1.9 pct)                              
  Recurring         17.52           12.56                                
                                 (-12.6 pct)                             
  Net               13.04            8.92                                
                                 (+27.8 pct)                             
  EPS            114.27 yen       78.20 yen                              
  EPS Diluted    113.94 yen       77.97 yen                              
  Ann Div         36.00 yen       28.00 yen      37.00 yen               
  -Q2 Div         15.00 yen       13.00 yen      18.00 yen               
  -Q4 Div         21.00 yen       15.00 yen      19.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news